Bruce C. Cozadd
2012
In 2012, Bruce C. Cozadd earned a total compensation of $11.1M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 209% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $1,081,600 |
---|---|
Option Awards | $4,627,340 |
Salary | $722,158 |
Stock Awards | $4,682,990 |
Other | $1,710 |
Total | $11,115,798 |
Cozadd received $4.7M in stock awards, accounting for 42% of the total pay in 2012.
Cozadd also received $1.1M in non-equity incentive plan, $4.6M in option awards, $722.2K in salary and $1.7K in other compensation.
Rankings
In 2012, Bruce C. Cozadd's compensation ranked 347th out of 11,487 executives tracked by ExecPay. In other words, Cozadd earned more than 97.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 347 | 97th |
Manufacturing | 130 | 97th |
Chemicals And Allied Products | 27 | 98th |
Drugs | 14 | 99th |
Pharmaceutical Preparations | 11 | 98th |
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2012.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019